Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 132 | 70,570 | 75 | 72 | 72 |
| Gross Profit | 132 | 70,570 | 75 | 72 | 72 |
| Operating Expenses | 122,881 | 110,583 | 106,842 | 93,938 | 87,543 |
| Operating Income | -122,749 | -40,013 | -106,767 | -93,866 | -87,471 |
| Interest Expense | 3,288 | 560 | 514 | 586 | 484 |
| Other Income | 5,682 | 5,974 | 6,546 | 7,540 | 8,230 |
| Pre-tax Income | -120,355 | -34,599 | -100,735 | -86,912 | -79,725 |
| Net Income Continuous | -120,355 | -34,599 | -100,735 | -86,912 | -79,725 |
| Net Income | $-120,355 | $-34,599 | $-100,735 | $-86,912 | $-79,725 |
| EPS Basic Total Ops | -1.11 | -0.34 | -1.00 | -0.87 | -0.83 |
| EPS Basic Continuous Ops | -1.31 | -0.42 | -1.23 | -1.07 | -1.01 |
| EPS Diluted Total Ops | -1.11 | -0.34 | -1.00 | -0.87 | -0.83 |
| EPS Diluted Continuous Ops | -1.31 | -0.42 | -1.23 | -1.07 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -1.08 | -0.34 | -1.00 | -0.87 | -0.81 |
| EBITDA(a) | $-124,382 | $-41,036 | $-108,309 | $-95,966 | $-90,555 |